BLISS GVS PHARMA LTD. - 506197 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1212 Name of the Signatory :- Aditi BhattDesignation :- Company Secretary and Compliance Officer BLISS GVS PHARMA LTD. - 506197 - Shareholding for the Period Ended September 30, 2021
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2021. Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the following shareholder: Bliss GVS Pharma Ltd - 506197 - Closure of Trading Window
This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Friday, October 01, 2021 until 48 hours after the announcement of the Unaudited financial results of the Company for the quarter and half year ended September 30, 2021. BLISS GVS PHARMA LTD. - 506197 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Bliss GVS Pharma Ltd - 506197 - Disclosure Of Voting Results Of The 36Th Annual General Meeting Of Bliss GVS Pharma Limited Held On September 21, 2021 Along With Scrutinizer'S Report
In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 36th Annual General Meeting of the Company held on Tuesday, September 21, 2021 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 36th Annual General Meeting. BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Events Or Information - 36Th Annual General Meeting Held On Tuesday, September 21, 2021
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 36th Annual General Meeting held on Tuesday, September 21, 20201 at 11:00 am through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). Bliss GVS Pharma Ltd - 506197 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find the attachment. Bliss GVS Pharma Ltd - 506197 - Purchase Of Immovable Property At Halol, Vadodara
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that, the Company has purchased Immovable Property situated at Vadodara, Gujarat. Please see attachment for more details. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification or re-enactment thereof for the time being in force), the Trading Window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for all the Designated Persons and their immediate relatives w.e.f. Monday, September 20, 2021 till Monday, September 27, 2021. In view of above, all Designated Persons and their immediate relatives are advised not to deal (buy or sell or pledge) in Securities/Shares of Bliss GVS Pharma Limited during the said period.